DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+12.06%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.98B
AUM Growth
+$1.98B
(+0.88%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-9.04%
Top 10 Holdings %
Top 10 Hldgs %
29.8%
Holding
137
New
25
Increased
17
Reduced
34
Closed
28
Top Buys
| 1 |
THOR
THORATEC CORPORATION
THOR
|
$33.2M |
| 2 |
Viatris
VTRS
|
$29.7M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$28.9M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$25.7M |
| 5 |
Traws Pharma
TRAW
|
$25.6M |
Top Sells
Sector Composition
| 1 | Healthcare | 56.8% |
| 2 | Technology | 1.47% |
| 3 | Financials | 1.14% |
| 4 | Consumer Discretionary | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEMP
51
DELISTED
Cempra, Inc.
CEMP
| $9.24M | 0.43% |
803,516
-802,994
| -50% | -$9.23M |
|
52
Vanda Pharmaceuticals
VNDA
$279M
| $8.98M | 0.42% |
+820,000
| New | +$8.98M |
|
|
ZGNX
53
DELISTED
Zogenix, Inc.
ZGNX
| $8.3M | 0.39% |
560,331
+79,259
| +16% | +$1.17M |
|
54
Cross Country Healthcare
CCRN
$420M
| $8.12M | 0.38% |
1,343,464
-238,763
| -15% | -$1.44M |
|
55
Alphatec Holdings
ATEC
$2.32B
| $7.85M | 0.36% |
331,895
+25,845
| +8% | +$611K |
|
|
LPDX
56
DELISTED
LIPOSCIENCE INC COM
LPDX
| $6.91M | 0.32% |
1,382,350
+279,606
| +25% | +$1.4M |
|
|
ANTH
57
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $6.8M | 0.32% |
211,482
-5,603
| -3% | -$180K |
|
|
ARNA
58
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $6.41M | 0.3% |
121,658
-135,201
| -53% | -$7.12M |
|
59
Tempest Therapeutics
TPST
$46.6M
| $6.02M | 0.28% |
208
+18
| +9% | +$521K |
|
|
NSTG
60
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.46M | 0.25% |
+496,650
| New | +$5.46M |
|
|
CASM
61
DELISTED
CAS Medical Systems, Inc.
CASM
| $4.29M | 0.2% |
+3,200,000
| New | +$4.29M |
|
62
Agios Pharmaceuticals
AGIO
$2.36B
| $4.22M | 0.2% |
+151,050
| New | +$4.22M |
|
|
ESRX
63
DELISTED
Express Scripts Holding Company
ESRX
| $4.02M | 0.19% |
+65,000
| New | +$4.02M |
|
64
Rigel Pharmaceuticals
RIGL
$710M
| $3.82M | 0.18% |
106,773
-164,232
| -61% | -$5.88M |
|
65
TherapeuticsMD
TXMD
$12.8M
| $3.66M | 0.17% |
+25,000
| New | +$3.66M |
|
66
Novavax
NVAX
$1.2B
| $3.39M | 0.16% |
+53,849
| New | +$3.39M |
|
|
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.2M | 0.15% |
119,448
-407,962
| -77% | -$10.9M |
|
|
GEVA
68
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $3.17M | 0.15% |
+50,000
| New | +$3.17M |
|
|
LCAV
69
DELISTED
LCA-VISION INC
LCAV
| $2.63M | 0.12% |
730,856
-100,000
| -12% | -$360K |
|
|
SQNM
70
DELISTED
SEQUENOM INC NEW
SQNM
| $2.63M | 0.12% |
+985,000
| New | +$2.63M |
|
|
DRTX
71
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $2.5M | 0.12% |
275,979
-476,560
| -63% | -$4.31M |
|
|
WINT
72
DELISTED
Windtree Therapeutics Inc
WINT
| $2.33M | 0.11% |
84,857
-10,357
| -11% | -$284K |
|
73
Hologic
HOLX
$14.7B
| $1.99M | 0.09% |
96,330
+61,330
| +175% | +$1.27M |
|
|
ELN
74
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| $1.56M | 0.07% |
100,000
-65,084
| -39% | -$1.01M |
|
|
PTN
75
DELISTED
Palatin Technologies
PTN
| $1.38M | 0.06% |
80,000
| – | – |
|